Andreas Rummelt Net Worth & Insider Trades
Andreas Rummelt - Director, Alexion Pharmaceuticals, Inc
What is Andreas Rummelt's Net Worth?
The current estimated net worth of Alexion Pharmaceuticals, Inc's Director, Andreas Rummelt, is estimated to be about $4M . Andreas Rummelt owns about 12,786 units of Alexion Pharmaceuticals, Inc common stock. In the last 11 years at Alexion Pharmaceuticals, Inc, Andreas Rummelt has sold an estimated value of $4M worth.
What is Andreas Rummelt's Past Insider Trading?
Andreas Rummelt's largest purchase order was 9,015 units , worth over $263.57K on October 25, 2011. Andreas Rummelt's largest sale order was 10,000 units , worth over $1.07M on July 31, 2012. In total, Andreas Rummelt has made about 25 transactions over 11 years of their time at Alexion Pharmaceuticals, Inc. Andreas Rummelt usually trades in May, with the busiest year in 2012. The most recent transaction was a sale order of 5,052 units , worth over $861.52K on August 27, 2014.
Andreas Rummelt
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is Andreas Rummelt's' Mailing Address?
- Mailing address is C/o Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire CT 06410 CT
Alexion Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Ludwig Hantson | 2019 | $1,250,000 | - | $15,243,634 | - | $2,430,000 | $24,350 | $18,947,984 |
Ludwig Hantson | 2018 | $1,200,000 | - | $12,385,168 | - | $2,880,000 | $25,082 | $16,490,250 |
Ludwig Hantson | 2017 | $900,000 | - | $9,618,758 | $2,282,881 | $2,275,000 | $233,428 | $15,310,067 |
Aradhana Sarin | 2019 | $651,764 | - | $3,380,763 | - | $813,011 | $31,604 | $4,877,142 |
Paul Clancy | 2019 | $927,000 | - | $3,863,694 | - | $1,051,218 | $23,832 | $5,865,744 |
Paul Clancy | 2018 | $900,000 | - | $3,302,761 | - | $1,260,000 | $23,752 | $5,486,513 |
Paul Clancy | 2017 | $415,385 | $500,000 | $8,799,954 | $1,220,082 | $473,620 | $2,262 | $11,411,303 |
Brian Goff | 2019 | $740,000 | - | $3,863,694 | - | $923,076 | $20,240 | $5,547,010 |
Brian Goff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $111,873 | $4,876,796 |
Brian Goff | 2017 | $381,634 | $100,000 | $2,390,026 | $732,899 | $434,380 | $58,787 | $4,097,726 |
Anne-Marie Law | 2019 | $695,000 | - | $3,622,303 | - | $788,130 | $33,528 | $5,138,961 |
Anne-Marie Law | 2018 | $650,000 | - | $2,889,885 | - | $910,000 | $846,604 | $5,296,489 |
Anne-Marie Law | 2017 | $362,500 | $200,000 | $2,300,015 | - | $410,472 | $68,710 | $3,341,697 |
John Orloff | 2019 | $770,000 | - | $3,863,694 | - | $960,498 | $32,550 | $5,626,742 |
John Orloff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $98,679 | $4,863,602 |
John Orloff | 2017 | $376,442 | $200,000 | $2,499,995 | - | $472,500 | $80,351 | $3,629,288 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm
What are Alexion Pharmaceuticals, Inc's Past Insider Trades?
Alexion Pharmaceuticals, Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals, Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director, Stephen Squinto, EVP, and Vikas Sinha, EVP & CFO .
ALEXION PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |